AICGX
Price
$36.88
Change
+$0.39 (+1.07%)
Updated
Dec 20 closing price
VIVAX
Price
$66.44
Change
+$0.77 (+1.17%)
Updated
Dec 20 closing price
Ad is loading...

AICGX vs VIVAX

Header iconAICGX vs VIVAX Comparison
Open Charts AICGX vs VIVAXBanner chart's image
American Century Discplnd Cor Val R5
Price$36.88
Change+$0.39 (+1.07%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$66.44
Change+$0.77 (+1.17%)
VolumeN/A
CapitalizationN/A
AICGX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AICGX vs. VIVAX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AICGX is a Buy and VIVAX is a Hold.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. AICGX (1.96B). VIVAX pays higher dividends than AICGX: VIVAX (2.25) vs AICGX (1.57). AICGX was incepted earlier than VIVAX: AICGX (8 years) vs VIVAX (32 years). AICGX is a more actively managed with annual turnover of: 179.00 vs. VIVAX (10.00). AICGX has a lower initial minimum investment than VIVAX: AICGX (0) vs VIVAX (3000). VIVAX (15.15) and AICGX (14.69) have marching annual gain over last year. VIVAX return over 5 years is better than : 41.35 vs. AICGX (3.53).
AICGXVIVAXAICGX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years32 years-
Gain YTD14.13014.000101%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.96B195B1%
Annual Yield % from dividends1.572.2570%
Returns for 1 year14.6915.1597%
Returns for 3 years11.9818.2566%
Returns for 5 years3.5341.359%
Returns for 10 yearsN/A99.53-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.560.12
+4.92%
CytoMed Therapeutics Limited
AQN4.390.08
+1.86%
Algonquin Power & Utilities Corp
BIIB146.47-0.92
-0.62%
Biogen
DOLE13.70-0.11
-0.80%
Dole plc
BNTC11.52-0.64
-5.30%
Benitec Biopharma